Machine learning for predicting diabetes risk in western China adults
Diabetes mellitus is a global epidemic disease. Long-time exposure of patients to hyperglycemia can lead to various type of chronic tissue damage. Early diagnosis of and screening for diabetes are crucial to p... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 27, 2023 Category: Endocrinology Authors: Lin Li, Yinlin Cheng, Weidong Ji, Mimi Liu, Zhensheng Hu, Yining Yang, Yushan Wang and Yi Zhou Tags: Research Source Type: research
The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
We aimed to assess the association between the use of Glucagon-like peptide-1 receptor agonists and the risk of 12 respiratory diseases in patients with type 2 diabetes, obesity, or overweight. (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 26, 2023 Category: Endocrinology Authors: Meixin Yu, Ruxin Wang, Ling Pei, Xiaofang Zhang, Jinjing Wei, Yun Wen, Han Liu, Haowen Ye, Jinghao Wang and Lihong Wang Tags: Research Source Type: research
Pragmatic clinic-based investigation of echocardiogram parameters in asymptomatic patients with type 2 diabetes in routine clinical practice and its association with suggestive coronary artery disease: a pilot study
Patients with diabetes mellitus (DM) have cardiovascular diseases (CVD) as a major cause of mortality and morbidity. The primary purpose of this study was to assess the echocardiographic parameters that showed... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 22, 2023 Category: Endocrinology Authors: Catia Cristina Silva Sousa Vergara Palma, Pablo Moura Lopes, Alfredo de Souza Bomfim and Marilia Brito Gomes Tags: Research Source Type: research
Correcting calculation and data errors reveals that the original conclusions were incorrect in “The best drug supplement for obesity treatment: a systematic review and network meta-analysis”
The goal of this study was to reproduce and evaluate the reliability of the network meta-analysis performed in the article “The best drug supplement for obesity treatment: A systematic review and network meta-... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 22, 2023 Category: Endocrinology Authors: Xiaoxin Yu, Patrice L. Capers, Roger S. Zoh and David B. Allison Tags: Brief Report Source Type: research
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four leading diabetes societies to... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 19, 2023 Category: Endocrinology Authors: Marcello Casaccia Bertoluci, Wellington S. Silva J únior, Fernando Valente, Levimar Rocha Araujo, Ruy Lyra, João Jácome de Castro, João Filipe Raposo, Paulo Augusto Carvalho Miranda, Cesar Luiz Boguszewski, Alexandre Hohl, Rui Duarte, João Eduardo Nu Tags: Review Source Type: research
Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy
Diabetic cardiomyopathy (DC) is a serious heart disease caused by diabetes. It is unrelated to hypertension and coronary artery disease and can lead to heart insufficiency, heart failure and even death. Curren... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 19, 2023 Category: Endocrinology Authors: Xuehua Yan, Yang Xie, Hongbing Liu, Meng Huang, Zhen Yang, Dongqing An and Guangjian Jiang Tags: Review Source Type: research
Syndecan-4 as a genetic determinant of the metabolic syndrome
Syndecan-4 (SDC4) is a member of the heparan sulfate proteoglycan family of cell-surface receptors. We and others previously reported that variation in the SDC4 gene was associated with several components of the ... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 17, 2023 Category: Endocrinology Authors: Paolina Crocco, Denise Vecchie, Sreejit Gopalkrishna, Serena Dato, Giuseppe Passarino, Martin E. Young, Prabhakara R. Nagareddy, Giuseppina Rose and Maria De Luca Tags: Research Source Type: research
The metabolic score for insulin resistance in the prediction of major adverse cardiovascular events in patients after coronary artery bypass surgery: a multicenter retrospective cohort study
The metabolic score for insulin resistance (METS-IR) is a simple, convenient, and reliable marker for resistance insulin (IR), which has been regarded as a predictor of cardiovascular disease (CVD) and cardiov... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 17, 2023 Category: Endocrinology Authors: Shuai Zhang, Zhenguo Wu, Yifan Zhuang, Xiangfei Sun, Juan Wang, Sha Chen, Dachuan Guo, Panpan Xu, Cheng Zhang and Jianmin Yang Tags: Research Source Type: research
The evaluation of cognitive-behavioral therapy-based intervention on type 2 diabetes patients with comorbid metabolic syndrome: a randomized controlled trial
Cognitive behavior therapy (CBT) has been applied in intervention research in diabetes patients with satisfying results. However, there was no research on type 2 diabetes (T2DM) patients with comorbidities. Th... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 17, 2023 Category: Endocrinology Authors: Yanni Li, Nicholas Buys, Samantha Ferguson, Zhiyong Li, Yan-Chuan Shi, Li Li and Jing Sun Tags: Research Source Type: research
Identification of key DNA methylation changes on fasting plasma glucose: a genome-wide DNA methylation analysis in Chinese monozygotic twins
Elevated fasting plasma glucose (FPG) levels can increase morbidity and mortality even when it is below the diagnostic threshold of type 2 diabetes mellitus (T2DM). We conducted a genome-wide DNA methylation a... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 17, 2023 Category: Endocrinology Authors: Weijing Wang, Wenqin Yao, Qihua Tan, Shuxia Li, Haiping Duan, Xiaocao Tian, Chunsheng Xu and Dongfeng Zhang Tags: Research Source Type: research
Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial
The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians ’ ability to risk stratify, diagno... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 13, 2023 Category: Endocrinology Authors: John W. Peabody, David Paculdo, Enrico de Belen, Divya Ganesan, Isabella Cooney and Nelson Trujillo Tags: Research Source Type: research
Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are commonly used in the management of type 2 diabetes mellitus (T2DM) and have been found to worsen the reduction of skeletal muscle mass in individuals with... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 12, 2023 Category: Endocrinology Authors: Xudong Yang, Lifeng Wang, Liangzhi Zhang, Xia Zhai, Xiusheng Sheng, Hengjun Lin and Helong Quan Tags: Research Source Type: research
Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT)
Recent studies have shown that the addition of sodium-glucose co-transporter 2 (SGLT2) inhibitors gradually reduces the estimated fluid volume parameters in a broad range of patient populations, suggesting tha... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 7, 2023 Category: Endocrinology Authors: Atsushi Tanaka, Takumi Imai, Shigeru Toyoda, Kazuhiro Sugimoto, Ruka Yoshida, Machi Furuta and Koichi Node Tags: Research Source Type: research
Correction: Efficacy of ozone therapy on visual evoked potentials in diabetic patients
(Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 7, 2023 Category: Endocrinology Authors: Morteza Izadi, Mohammad Javanbakht, Ali Sarafzadeh, Behzad Einollahi, Farzaneh Futuhi, Zahra Vahedi, Shi Zhao, Nematollah Jonaidi ‑Jafari, Mahboobeh Sadat Hosseini, Javad Hosseini Nejad, Effat Naeimi, Seyed Hassan Saadat, Hadi Esmaeili Gouvarchin Ghaleh Tags: Correction Source Type: research
Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control with drugs may reduce long-term CVD risk. Br... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 6, 2023 Category: Endocrinology Authors: Mulualem Tesfaye Birhan, Teklie Mengie Ayele, Fikire Wondimu Abebe and Fiseha Nigussie Dgnew Tags: Research Source Type: research
